GABA B receptor antagonist CGP-36742 enhances somatostatin release in the rat hippocampus in vivo and in vitro

By Nyitrai G.   Kekesi K.A.   Emri Z.   Szarics E.   Juhasz G.   Kardos J.  

European Journal of Pharmacology, Vol. 478, Iss. 2, 2003-10 ,pp. : 111-119

Elsevier

Access to resources Recommend Favorite

Potency and selectivity of the tachykinin NK 3 receptor antagonist SR142801

By Beaujouan J.-C.   Saffroy M.   Torrens Y.   Glowinski J.  

European Journal of Pharmacology, Vol. 319, Iss. 2, 1997-01 ,pp. : 307-316

Elsevier

Access to resources Recommend Favorite

In vitro and in vivo pharmacology of S 16474, a novel dual tachykinin NK 1 and NK 2 receptor antagonist

By Robineau P.   Lonchampt M.   Kucharczyk N.   Krause J.E.   Regoli D.   Fauchere J.-L.   Prost J.-F.   Canet E.  

European Journal of Pharmacology, Vol. 294, Iss. 2, 1995-12 ,pp. : 677-684

Elsevier

Access to resources Recommend Favorite

Inhibition of shock-induced foot tapping behaviour in the gerbil by a tachykinin NK 1 receptor antagonist

By Ballard T.M.   Sanger S.   Higgins G.A.  

European Journal of Pharmacology, Vol. 412, Iss. 3, 2001-02 ,pp. : 255-264

Elsevier

Access to resources Recommend Favorite

Pharmacological re-evaluation of a GABA B receptor antagonist CGP 47332A in rat brain

By Ong J.   Marino V.   Parker D.A.S.   Kerr D.I.B.   Froestl W.  

European Journal of Pharmacology, Vol. 383, Iss. 2, 1999-10 ,pp. : 137-141

Elsevier

Access to resources Recommend Favorite